Advances in Peptide Therapeutics (Technical Insights)

HealthcareAdvances in Peptide Therapeutics (Technical Insights)

 

RELEASE DATE
30-Sep-2010
REGION
Global
Deliverable Type
Technology Research
Research Code: D21C-01-00-00-00
SKU: HC01289-GL-TR_05556
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC01289-GL-TR_05556

Advances in Peptide Therapeutics (Technical Insights)
Published on: 30-Sep-2010 | SKU: HC01289-GL-TR_05556

Need more details?

$4,950.00

$3,712.50save 25 %

DownloadLink
Need more details?

Peptides have been prevalent as biopharmaceutical entities since the past twenty years but have come into focus only in the last five to six years due to improvements in manufacturing processes and delivery technologies. This research service aims to provide a strategic picture of therapeutic peptides from a research and development portfolio perspective and delineate the most critical criteria to be considered during evaluation of R&D portfolio projects. Using the current research scenario, market potential data and technical features of peptide drugs as tools, it provides a decision-making base for stakeholders at all stages in this industrial sector from small biotechnology companies to big pharmaceutical organizations.

Advances in Peptide Therapeutics

  • Advances in Peptide Therapeutics
Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Peptides have been prevalent as biopharmaceutical entities since the past twenty years but have come into focus only in the last five to six years due to improvements in manufacturing processes and delivery technologies. This research service aims to provide a strategic picture of therapeutic peptides from a research and development portfolio perspective and delineate the most critical criteria to be considered during evaluation of R&D portfolio projects. Using the current research scenario, market potential data and technical features of peptide drugs as tools, it provides a decision-making base for stakeholders at all stages in this industrial sector from small biotechnology companies to big pharmaceutical organizations.
More Information
Deliverable Type Technology Research
No Index Yes
Podcast No
Industries Healthcare
WIP Number D21C-01-00-00-00
Is Prebook No